Basel, 6 - 8 October 2025

Schedule

Create your personal agenda –check the favourite icon

Oct 69:00
Conference pass
Oct 69:20
Conference pass

The In-Silico Slingshot: Redefining Drug Development in the Age of AI

Keynotes

As traditional R&D models strain under rising costs and declining ROI, the pharmaceutical industry stands at a tipping point. This keynote explores how in-silico methods—powered by AI, digital twins, and virtual trials—are transforming drug development from end to end, revolutionizing everything from pre-clinical safety studies and dose optimization to clinical trial design, regulatory submissions and post-marketing expansion.

We’ll explore the science, the systems, and the strategy behind this transformative shift. Attendees will gain insight into how organizations can embrace this paradigm, build future-ready capabilities, and lead in a data-driven, AI-enabled era of drug development.

Aaron Mitchell, Principal, ZS
Oct 611:40
Conference pass

Chair's remarks

AI in Drug Development and Discovery
Franck Augé, Director R&D Search and Evaluation AI and Digital Technologies, SERVIER
Oct 611:40
Conference pass

Chair's remarks

Cheminformatics
Werngard Czechtizky, Executive Director Head of Medicinal Chemistry, AstraZeneca
Oct 611:40
Conference pass
Oct 611:40
Conference pass
Oct 611:40
Conference pass

Chair's remarks

Digital Transformation
Angelika Fuchs, Chapter Lead Data Products and Platforms, Roche
Oct 611:40
Conference pass

Chair's remarks

Data Management, Storage and Architecture
Pierre Fischer, Product Line Lead Data Platforms, F. Hoffmann-La Roche Ltd
Oct 611:40
Conference pass

Chair's remarks

Data Integration + FAIR
Martin Romacker, Product Manager – Roche Data Marketplace, Roche
Oct 611:40
Conference pass

Chair's remarks

Analytics Platform
Stefan Schmitz, Head of Data Science Technology Enablement, Bayer AG
Oct 611:40
Conference pass

Chair's remarks

AI in Clinical Trials
Rana Abou Antoun, Global Commercial Director Cell and Gene, Novartis
Oct 611:45
Conference pass

Integrating and contextualizing multi-modal data for advancing personalized medicine

AI in Drug Development and Discovery
Carine Poussin, Head of AI for Life Sciences, CSEM
Oct 611:45
Conference pass

Predictive & Generative Modelling in Drug Design Opportunities and Challenges of Augmented Intelligence

Cheminformatics
Nils Weskamp, Associate Director Computational Chemistry / Data Science, Boehringer Ingelheim Pharma GmbH & Co. KG
Oct 611:45
Conference pass

AI immunology: a new era in vaccine discovery

Bioinformatics + In silico R&D
Andreas Holm Mattsson, Chief AI Officer, Evaxion Biotech
Oct 611:45
Conference pass

Upscaling for future pharma fit processes

Large Language Models
Carolina Benjaminsen, Senior Director and Head of Digital Science Academy for R&ED, Novo Nordisk
Oct 611:45
Conference pass

Machine learning and multi-modal data for target discovery and patient understanding

Big Data in Oncology
Sina Nassiri, Principal Bioinformatics Scientist, Roche Pharma
Oct 611:45
Conference pass

Bayer's Digital Transformation in R&D: what are the key catalysts

Digital Transformation
Claudia Vogt, Chief of Staff R&D Data Science & AI, Bayer AG
Oct 611:45
Conference pass

5 new ways to sabotage your R&D data platform

Data Management, Storage and Architecture
Maks Shah, Head Data Design Authority, Syngenta Crop Protection
Oct 611:45
Conference pass

Advanced meta data exchange for healthcare

Data Integration + FAIR
Steffen Vogler, Senior Imaging Technology Scientist, Bayer
Oct 611:45
Conference pass

Advanced gut-on-a-chip platform for therapeutic target identification

Analytics Platform
Paul Wilmes, Full Professor of Systems Ecology, University of Luxembourg
Oct 611:45
Conference pass

Eligibility Criteria Builder

AI in Clinical Trials
Shagun Grover, Product Lead - Study Design & Protocol Optimization, Roche
Oct 611:45
Conference pass

Real world evidence at a tertiary children’s hospital

Real World Evidence
Catherine Brownstein, Assistant Professor, Harvard Medical School
Oct 612:25
Conference pass

ML in drug discovery

AI in Drug Development and Discovery
Damian Roqueiro, Senior Scientist, Roche
Oct 612:25
Conference pass

Application of LLM in drug discovery

Cheminformatics
Werngard Czechtizky, Executive Director Head of Medicinal Chemistry, AstraZeneca
Oct 612:25
Conference pass

Event driven architecture for HT proteomics

Bioinformatics + In silico R&D
Francisco Bonachela Capdevila, TPO High Dimensional Biology and Bioinformatics,, JnJ
Oct 612:25
Conference pass

AI agents for translational medicine

Large Language Models
Oct 612:25
Conference pass

Identification of small molecules targeting rna

Big Data in Oncology
Antoine de Weck, Group Leader, Children's cancer Institute
Oct 612:25
Conference pass

Patient finding

Digital Transformation
Oct 612:25
Conference pass

FAIR In-vivo data Sharing: Enabling in-vivo workflows using a FAIR by design platform

Data Integration + FAIR
Anastasios Moresis, Principal Scientist Data Products and Platforms, Roche
Oct 612:25
Conference pass

Accelerating ML Deployment: Operationalizing Kubeflow for Scalable Drug Discovery at Roche

Analytics Platform
Malgorzata Bartosik, Senior IT Professional Data Science, Roche Polska Sp. Zoo
Oct 612:25
Conference pass

Boosting clinical data management with genAI

AI in Clinical Trials
Ercan Suekuer, Senior AI Clinical Data Scientist, Roche
Oct 612:25
Conference pass

RWE at UCB

Real World Evidence
Johann de Jong, Associate Director, Global Advanced Analytics, UCB Pharma
Oct 613:05
Conference pass

Early involvement of patients in clinical trials to develop innovative treatments (Gene Therapies)

AI in Drug Development and Discovery
Theodora Weisz, Head of Patient Advocacy and Public Affairs, Novartis Gene Therapies, Novartis Gene Therapies
Oct 613:05
Conference pass

The OpenChemLib: Powering Cheminformatics at Idorsia

Cheminformatics
Oct 613:05
Conference pass

Systems toxicology: leveraging in silico and bioinformatics potential in preclinical drug safety

Bioinformatics + In silico R&D
Oct 613:05
Conference pass

Power of LLMs in pre clinical drug discovery

Large Language Models
Shayoni Dutta, Data Science Manager, GlaxoSmithKline
Oct 613:05
Conference pass

Integrative longitudinal functional genomics To Identify Novel treatment Induced Cancer Vulnerabilities

Big Data in Oncology
Simon McDade, Professor of Functional Genomics, Queen's University Belfast
Oct 613:05
Conference pass
Oct 613:05
Conference pass

Journey to democratise data: the good, the bad, the ugly

Data Management, Storage and Architecture
Pierre Fischer, Product Line Lead Data Platforms, F. Hoffmann-La Roche Ltd
Oct 613:05
Conference pass

Time Series Foundation Model (TSFM) for Forecasting in Pharma Supply Chain: Do they deliver?

Analytics Platform
Matias Callara, Senior Data Scientist, Roche
Oct 613:05
Conference pass

Digital twin for clinical trials

AI in Clinical Trials
Benjamin Gmeiner, Director and Head of Medical Data Strategy & Science, Novartis Pharma
Oct 613:05
Conference pass

AI in RWD

Real World Evidence
Abhishek Choudhary, Principal Data Engineer, Bayer AG
Oct 613:25
Conference pass

Networking Lunch

Keynotes
Anna Abiola, Senior Producer, Terrapinn Holdings Ltd
Oct 614:25
Conference pass

Chair's remarks

AI in Drug Development and Discovery
Caroline Gubser Keller, Global Head Data Science -Discovery Sciences, Novartis Biomedical Research
Oct 614:25
Conference pass

Chair's remarks

Cheminformatics
David Drake, Drug Discovery IT Capability Lead, Astrazeneca
Oct 614:25
Conference pass

Chair's remarks

Bioinformatics + In silico R&D
Derya Aytan-Aktug, Senior Bioinformatics Scientist, Leo Pharma
Oct 614:25
Conference pass
Oct 614:25
Conference pass
Oct 614:25
Conference pass
Oct 614:25
Conference pass

Chair's remarks

Data Management, Storage and Architecture
Pierre Fischer, Product Line Lead Data Platforms, F. Hoffmann-La Roche Ltd
Oct 614:25
Conference pass

Chair's remarks

Data Integration + FAIR
Martin Romacker, Product Manager – Roche Data Marketplace, Roche
Oct 614:25
Conference pass

Chair's remarks

Analytics Platform
Alfred Stefan, Manager LU Informatics, AbbVie
Oct 614:25
Conference pass

Chair's remarks

AI in Clinical Trials
Oct 614:25
Conference pass

Chair's remarks

Real World Evidence
Shahed Iqbal, Executive Director and Head, Molecular Epidemiology, Biomarker Sciences, Gilead Sciences
Oct 614:30
Conference pass

Harnessing AI for Drug Discovery to Accelerate, Enhance, and Innovate

AI in Drug Development and Discovery
Caroline Gubser Keller, Global Head Data Science -Discovery Sciences, Novartis Biomedical Research
Oct 614:30
Conference pass

Drug Development Data Platform and In Silico R&D

Bioinformatics + In silico R&D
Echedey Lorenzo, Lead Data Engineer, Research Data Platform, AstraZeneca
Oct 614:30
Conference pass

The ”Majority Illusion” in DLBCL Lessons we have learned from social media help us identify cancer’s biomarkers

Big Data in Oncology
Luciano Cascione, Head of Bioinformatics Core Unit, Institute of oncology research (IOR),
Oct 614:30
Conference pass

KM enabled digital transformation

Digital Transformation
Joseph Pisari, Knowledge Management Team Lead, Novartis
Oct 614:30
Conference pass

Preparing biomedical research data landscape to be AI ready

Data Management, Storage and Architecture
Ralph Haffner, VP Research Informatics, Novartis, Biomedical Research
Oct 614:30
Conference pass

FAIR meta data management to accelerate data integration and insight generation

Data Integration + FAIR
Martin Romacker, Product Manager – Roche Data Marketplace, Roche
Oct 614:30
Conference pass

Operational simulation framework for internal programme modelling

Analytics Platform
Jin Hyun Ju, Director of Data Science, BridgeBio
Oct 614:30
Conference pass

How Federated Learning in AI can improve clinical trials quality

AI in Clinical Trials
Alessandro Raimondo, Business Development Manager, CERN
Oct 614:30
Conference pass

Evidence generation strategies federated learning

Real World Evidence
Oct 614:50
Conference pass

Improved disease protein prioritization from omics data through network embedding

Analytics Platform
Lars Juhl Jensen, Director, ZS
Oct 615:10
Conference pass

Generative Chemistry

AI in Drug Development and Discovery
Antoine Taly, Researcher, CNRS
Oct 615:10
Conference pass

Applying Predictive Modelling to Improve Early-Stage Drug Discovery

Cheminformatics
Prakash Rathi, Director, R&DIT, Data Analytics and AI, AstraZeneca
Oct 615:10
Conference pass

In silico darpin therapeutics

Bioinformatics + In silico R&D
Ana Filipa Fonseca, Director, Global RLT Strategy & Early Portfolio, Novartis
Oct 615:10
Conference pass

LLMs across pharma value chain

Large Language Models
Waheed Jowiya, Digitalisation Strategy Lead, Novo Nordisk
Louise Lind Skov, Director of Content Digitalisation, Novo Nordisk
Oct 615:10
Conference pass

Accelerating clinical trials using AI

Big Data in Oncology
Oct 615:10
Conference pass

Digital services with medical products

Digital Transformation
Oct 615:10
Conference pass

Navigating the Data Fabric: Debiopharm's Journey to Mastering Clinical and Pre-Clinical Data

Data Management, Storage and Architecture
Frederico Braga, Head of Digital and IT, Debiopharm
Oct 615:10
Conference pass

Sharing antiviral discovery data to accelerate therapeutic discovery

Data Integration + FAIR
Oct 615:10
Conference pass

The shift of Analytics Platforms and organizations in light of AI

Analytics Platform
Oct 615:10
Conference pass

Generative AI & the Importance of Having a Well Crafted Data Strategy

AI in Clinical Trials
Oct 615:10
Conference pass

Impact of RWE in cannabinoids based medicines

Real World Evidence
Ana Serrato, Head Clinical Development, Avextra
Oct 615:50
Conference pass

Agents to connect all the dots

AI in Drug Development and Discovery
Dennis Madsen, Scientific Director, Novo Nordisk A/S
Oct 615:50
Conference pass

Data driven approach to Targeted glues drug discovery

Bioinformatics + In silico R&D
Liliana Greger, Senior Director of Bioinformatics, Amphista Therapeutics
Oct 615:50
Conference pass

LLMs at Bayer

Large Language Models
Jordi Casanellas, Head of Language AI, Bayer
Oct 615:50
Conference pass

Translating Big Data in Oncology for Clinical Benefit: Unlocking Insights for Better Patient Outcomes

Big Data in Oncology
Anne Zuse, Clinical Scientist Associate Director, Novartis
Oct 615:50
Conference pass

Digital transformation & Pharma GTM model

Digital Transformation
Barbara Albientz, Chief Commercial Officer, Helvion Pharma
Oct 615:50
Conference pass

Transform genomic and biological data into insights

Data Management, Storage and Architecture
Kortine Kleinheinz, Digital Lead for Research IT, Bayer AG
Oct 615:50
Conference pass

Swiss personalised health network

Data Integration + FAIR
Sabine Österle, Lead Sematic Interoperability Strategy and FAIR Data Team, SIB Swiss Institute of Bioinformatics
Oct 615:50
Conference pass

Building a group wide-data platform

Analytics Platform
Christophe Chabbert, Group Lead, Data & AI, Octapharma Biopharmaceuticals GmbH
Oct 615:50
Conference pass

Machine learning algorithms as trial endpoints

AI in Clinical Trials
Martin de Borst, Nephrologist and Professor of Medicine, University Medical Centre Groningen
Oct 615:50
Conference pass

NHS secured data environments for RWE generation

Real World Evidence
Adrian Jonas, Chief Analyst for the North West Region, NHS
Oct 616:10
Conference pass

Networking Break

Keynotes
Anna Abiola, Senior Producer, Terrapinn Holdings Ltd
Oct 616:40
Conference pass

Chair's remarks

AI in Drug Development and Discovery
John Wise, Consultant, Pistoia Alliance
Oct 616:40
Conference pass

Chair's remarks

Cheminformatics
Nils Weskamp, Associate Director Computational Chemistry / Data Science, Boehringer Ingelheim Pharma GmbH & Co. KG
Oct 616:40
Conference pass

Chair's remarks

Bioinformatics + In silico R&D
Werngard Czechtizky, Executive Director Head of Medicinal Chemistry, AstraZeneca
Oct 616:40
Conference pass
Oct 616:40
Conference pass

Chair's remarks

Big Data in Oncology
Crina Samarghitean, Medical Doctor, Tampere University
Oct 616:40
Conference pass
Oct 616:40
Conference pass

Chair's remarks

Data Management, Storage and Architecture
Pierre Fischer, Product Line Lead Data Platforms, F. Hoffmann-La Roche Ltd
Oct 616:40
Conference pass

Chair's remarks

Data Integration + FAIR
Martin Romacker, Product Manager – Roche Data Marketplace, Roche
Oct 616:40
Conference pass

Chair's remarks

AI in Clinical Trials
Oct 616:40
Conference pass

Chair's remarks

Real World Evidence
Neehar Kundurti, Faculty, tulane university school of medicine
Oct 616:45
Conference pass

Applied AI use cases in drug discovery and development

AI in Drug Development and Discovery
Anna Fournier, Principal Data Scientist, Swiss Data Science Center
Oct 616:45
Conference pass

Chemistry with Artificial Intelligence

Cheminformatics
Rolf Jautelat, VP R&D Data Science & AI, Bayer
Oct 616:45
Conference pass

Computational approaches for target discovery

Bioinformatics + In silico R&D
Becky Saunders, Associate Director, Computational Biologist, E-therapeutics
Oct 616:45
Conference pass

How we utilise generative AI at Novo Nordisk

Large Language Models
Peter Vester, Lead Data Scientist, Novo Nordisk
Oct 616:45
Conference pass

Unlocking biomedical big data for precision oncology with privacy-enhancing technologies

Big Data in Oncology
Sandra Barbosu, Associate Director, Information Technology and Innovation Foundation
Oct 616:45
Conference pass

Digital Transformation in pharmaceutical Manufacturing

Digital Transformation
Frank Thielmann, Head Function of the Future, Takeda
Oct 616:45
Conference pass

Data products and data marketplace success stories

Data Management, Storage and Architecture
Gaurav Grigo, Sr. Director, Head of Architecture & Systems Engineering, DDIT-R&ED, Novo Nordisk
Sandeep Majumder, Head of Data Management and Solutions, Novo Nordisk
Oct 616:45
Conference pass

Drug Development Data Platform and Data Integration + FAIR

Data Integration + FAIR
Ander Sainz Loyola, Lead Data Engineer, Research Data Platform, Astrazeneca
Oct 616:45
Conference pass

Microbial Genomics platform

Analytics Platform
Tim Roloff, Co Department Head Microbial Genomics, University of Zurich
Oct 616:45
Conference pass

Transforming Clinical Research with AI Agents

AI in Clinical Trials
Georgios Kavousanos, Senior AI Engineer, Novo Nordisk
Oct 616:45
Conference pass

AI agents for Evidence Generation

Real World Evidence
Thirupathi Pattipaka, Global Director, Data Science and AI, Novartis
Oct 617:05
Conference pass

(Cell) Painting by Numbers: Analysis Pipelines for Phenotypic Screening in Early Drug Discovery

Bioinformatics + In silico R&D

Alithea Genomics is a global leader in scalable transcriptomics solutions for screening applications.We support pharmaceutical, biotech, and agrochemical companies in accelerating and de-risking their compound selection processes.

Our proprietary high-throughput and ultra-low-cost RNA-seq library preparation technology (DRUG-seq) allows for transcriptomic data generation from thousands of samples in a streamlined and convenient workflow.

Our protocol requires no RNA extraction and has been validated on multiple cell lines. On the analysis side, we provide default upstream, downstream, and QC analysis, along with customized solutions from our team of expert bioinformaticians.Beyond library prep, sequencing, and data analysis, we also offer end-to-end, high-throughput cell culture, treatment, and imaging services (including cell painting).

Oct 617:05
Conference pass

ELaiN – the AI Scientific Assistant. How quickly they grow up

Digital Transformation

Rob will discuss the significant advancements in ELaiN, an AI-driven digital assistant designed to create experiment content and perform advanced scientific searches. He will highlight the remarkable progress that has been made and how ELaiN has evolved since the Lab of the Future Conference 2024.

For those that want to meet ELaiN already?https://www.sapiosciences.com/blog/sapio-elain-your-science-aware-ai-lab-assistant/

Oct 617:25
Conference pass

From Data to Diagnosis: The Power of Multi-Omics in Clinical Research

Bioinformatics + In silico R&D
Moderator: Ornella Cominetti, Senior Omics Data Specialist, Nestlé
Nerses Shahbazyan, Bioinformatics Scientist, Yerevan State Medical University
Silvia Ramirez, Global Digital Precision Healthcare Director, Astrazeneca
Oct 617:25
Conference pass

Are LLMs enough?

Large Language Models
Michele Siccardi, Executive Director, International Insights & Analytics (I&A), CSL Behring
Lee Clewley, VP, AI & Informatics, e-therapeutics plc
Oct 617:25
Conference pass

Using multi-modal patient level data in discovery and early development

Big Data in Oncology
Moderator: Shahed Iqbal, Executive Director and Head, Molecular Epidemiology, Biomarker Sciences, Gilead Sciences
Jake Chen, Endowed Professor and Founding Director, SPARC, University of Alabama at Birmingham
Dan Crowley, Chief Executive Officer, RemedyBio
Priyasma Bhoumik, Strategic Vendor Manager, PS AI Strategy Lead, Roche
Oct 617:25
Conference pass

Health Data Governance in the light of the new EU regulations

Data Management, Storage and Architecture
Moderator: Nicola Orlandi, Global Head of Data Privacy, Bausch & Lomb
Angela Mazzonetto, Chief Privacy Officer, Bruker
Pascal Hofer, Head of Legal Digital & IT, F. Hoffmann-La Roche AG
Gaurav Grigo, Sr. Director, Head of Architecture & Systems Engineering, DDIT-R&ED, Novo Nordisk
Oct 617:25
Conference pass

Turning Data into Action: Integrating Processes Analytically

Analytics Platform
Moderator: Francesco Orsi, Data Science Manager, Roche
Raul Mora, Senior Development Excellence Lead, Roche
Parag Dave, Head of Data, Digital, and Technology, Takeda
Andres Buser, Chapter Lead New Modality IP, F. Hoffmann - La Roche AG
Oct 617:25
Conference pass

Digital Twins in Drug Development: Accelerating Clinical Trial Timelines

AI in Clinical Trials
Moderator: Mara Hummel, Sr Clinical Operations Lead, Hoffmann-La Roche Ltd.
Mateus Patricio, Director Data Analytics & AI Engineering, Astrazeneca
Christian Eisen, Director Translational Science, AstraZeneca
Benjamin Gmeiner, Director and Head of Medical Data Strategy & Science, Novartis Pharma
Oct 617:25
Conference pass

Elevate health – improving patient care

Real World Evidence
Moderator: Petra Nathan, Global Head of Implementation Science, Boehringer Ingelheim
Michael Rebhan, Associate Director, Translational Research DS, Novartis
Manuela Maronati, Head of Rare Diseases Europe, UCB
Theodora Weisz, Head of Patient Advocacy and Public Affairs, Novartis Gene Therapies, Novartis Gene Therapies
Oct 618:05
Conference pass

Networking Drinks Reception

Keynotes
Anna Abiola, Senior Producer, Terrapinn Holdings Ltd

Create your personal agenda –check the favourite icon

Oct 79:05
Conference pass

Keynote Presentation

Keynotes
Etienne Delille, SVP, Global Chief Digital Information Officer, Ipsen
Oct 711:45
Conference pass

Chair's remarks

Bioinformatics + In silico R&D
Simon McDade, Professor of Functional Genomics, Queen's University Belfast
Oct 711:45
Conference pass
Oct 711:45
Conference pass

Chair's remarks

Large Language Models
Tankred Ott, Senior Data Scientist, Novo Nordisk
Oct 711:45
Conference pass

Chair's remarks

Digital Transformation
Maya Shevlyakova, Associate Director Global Digital Core, CSL Behring AG
Oct 711:45
Conference pass
Oct 711:45
Conference pass

Chair's remarks

AI in Clinical Trials
Raul Mora, Senior Development Excellence Lead, Roche
Oct 711:45
Conference pass
Oct 711:45
Conference pass

Chair's remarks

Image Analysis
Oct 711:50
Conference pass

Accelerating drug discovery for large molecules using AI ready data platforms

AI in Drug Development and Discovery
Sabyasachi Dasgupta, Global Head of R&D Data Platforms & Products, Sanofi
Oct 711:50
Conference pass

Discovery and engineering of next-gen immunotherapies with EMLy Co-pilot

Bioinformatics + In silico R&D
Jacob Hurst, Chief Technology Officer, Etcembly
Oct 711:50
Conference pass

LLMs and knowledge graphs

Large Language Models
Tankred Ott, Senior Data Scientist, Novo Nordisk
Oct 711:50
Conference pass

Realising value of digital transformation a real-world example

Digital Transformation
Inger Nielsen, Team lead, Digitalisation, Novo Nordisk
Oct 711:50
Conference pass

Before Gen AI, Get Your Data Right: Why FAIR Data Matters

Data Integration + FAIR
Oct 711:50
Conference pass

R&D analytics at your fingertips: the CSL scientific app store

Analytics Platform
Carmen Weber, Manager Data Excellence, CSL Behring
Oct 711:50
Conference pass

AI driven trial design and trial planning

AI in Clinical Trials
Jeremy Zhang, Sr Director, Advanced Analytics, Gilead Sciences
Oct 711:50
Conference pass
Oct 711:50
Conference pass

Foundational model for medical imaging

Image Analysis
Sadegh Mohammadi, Head of Computer Vision & Sound Analysis, Bayer AG
Oct 712:10
Conference pass

Sponsor -SAS

Large Language Models
José Miguel Fernández Pueyo, Biostatistics Manager, SGS - Pharma
Wesley Wuyts, Sr systems engineer, SAS
Oct 712:30
Conference pass

Deciphering immune landscape with AI

AI in Drug Development and Discovery
Oct 712:30
Conference pass

DigiMab: in-silico Antibody Discovery Platform

Bioinformatics + In silico R&D
Irem Nasir, R&D Engagement Lead, Sr. Data Scientist, Bayer
Oct 712:30
Conference pass

Integrating Single-Cell Multi-Omics into Clinical Trials: Paving the Way for Precision Medicine and Biomarker Discovery

Single Cell Genomics
Vivek Das, Lead Data Scientist, AI and Analytics, Novo Nordisk
Oct 712:30
Conference pass

Language of biology: using LLMs for drug target discovery

Large Language Models
Michal Pikusa, Associate Director and Senior Principal Data Scientist, Novartis
Oct 712:30
Conference pass

Increasing operational efficiencies: Driving Digital Adoption with Product Analytics

Digital Transformation
Liselle Mulcaire, Digital Product Operations, Development Digital Transformation, Novo Nordisk
Oct 712:30
Conference pass

Big Data in FAIR implementation from an international perspective

Data Integration + FAIR
Zisis Kozlakidis, Head of Laboratory Services and Biobanking, World Health Organization / International Agency For Research on Cancer
Oct 712:30
Conference pass

Data Science under One Roof OCEAN & NextGen @ Roche PD Data Sciences

Analytics Platform
Helene Royo, Senior Principal Data Science Product Leader, Roche
Oct 712:30
Conference pass

iQNow AI enabled approach to knowledge management

AI in Clinical Trials
Oct 712:30
Conference pass

Elevate health open science initiative

Real World Evidence
Michael Rebhan, Associate Director, Translational Research DS, Novartis
Oct 712:30
Conference pass

Image analysis in cryoEM to rationalise drug discovery

Image Analysis
Alexey Rak, Department Head, Bio Structure and Biophysics Integrated Drug Discovery,, SANOFI
Oct 713:10
Conference pass

Genomeasia 100K

Population Genomics
Hie Lim Kim, Assistant Professor, Asian School of Environment, NTU Singapore
Oct 713:10
Conference pass

Utilising multimodal data in early drug development

AI in Drug Development and Discovery
Matthias Orlowski, Principal ML Engineer, Bayer AG
Oct 713:10
Conference pass

Early target assessment

Bioinformatics + In silico R&D
Oct 713:10
Conference pass

Single cell barcoding technology to design treatment for ovarian cancer

Single Cell Genomics
Oct 713:10
Conference pass

Exploring the Future of Preclinical Research: Our AI Chatbot for Data Annotation, Retrieval and Writing Assistance

Large Language Models
Annika Kreuchwig, Senior Data Scientist, Bayer
Oct 713:10
Conference pass

The next steps towards customer centricity

Digital Transformation
Michael Zaiac, Head of Medical Affairs Oncology Europe and Canada, Daiichi Sankyo
Oct 713:10
Conference pass

FAIR Knowledge Graphs, benefits and challenges

Data Integration + FAIR
Oct 713:10
Conference pass

Sevier’s analytics platform

Analytics Platform
Thibaut Snollaerts, Senior Manager, Pre-clinical Data Management, SERVIER
Oct 713:10
Conference pass

Enhancing Drug Development: The Role of Digital Biomarkers in Clinical Trials

AI in Clinical Trials
Thanneer Perumal, Senior Principal Scientist, Roche
Oct 713:10
Conference pass

Evidence generation in early-stage drug development

Real World Evidence
Moritz Saxenhofer, Senior Manager Translational Research, CSL Behring
Oct 713:10
Conference pass

Phenomic immune-health profiling through self-supervised representation learning

Image Analysis
Oct 713:30
Conference pass

Networking Lunch

Keynotes
Anna Abiola, Senior Producer, Terrapinn Holdings Ltd
Oct 714:30
Conference pass

Chair's remarks

AI in Drug Development and Discovery
Giovanni Rizzo, Partner Biotech Fund, Indaco Venture Partners
Oct 714:30
Conference pass

Chair's remarks

Bioinformatics + In silico R&D
Simon McDade, Professor of Functional Genomics, Queen's University Belfast
Oct 714:30
Conference pass

Chair's remarks

Single Cell Genomics
Zhongyi Wang, Senior Expert II Data Science, Novartis
Oct 714:30
Conference pass

Chair's remarks

Large Language Models
Jake Chen, Endowed Professor and Founding Director, SPARC, University of Alabama at Birmingham
Oct 714:30
Conference pass

Chair's remarks

Digital Transformation
Oct 714:30
Conference pass

Chair's remarks

Data Integration + FAIR
Andrea Possenti, Associate Principal Data Scientist, AstraZeneca
Oct 714:30
Conference pass

Chair's remarks

Analytics Platform
Alfred Stefan, Manager LU Informatics, AbbVie
Oct 714:30
Conference pass

Chair's remarks

AI in Clinical Trials
Raul Mora, Senior Development Excellence Lead, Roche
Oct 714:30
Conference pass

Chair's remarks

Real World Evidence
Diar Fattah, Global Director, Innovative Value Strategies And Evidence (Respiratory), AstraZeneca
Oct 714:30
Conference pass

Chair's remarks

Image Analysis
Steffen Vogler, Senior Imaging Technology Scientist, Bayer
Oct 714:35
Conference pass

How to optimize AI quality methods to utilize prior knowledge

AI in Drug Development and Discovery
Etzard Stolte, Global Head Of Knowledge Management Ptd, Roche
Oct 714:35
Conference pass

Sabah Nature Wonders: For Sustainable Drug Development

Bioinformatics + In silico R&D
Syahriel Abdullah, Senior Lecturer / Researcher, Universiti Malaysia Sabah (UMS)
Oct 714:35
Conference pass

Leveraging single cell and spatial transcriptomics for target discovery

Single Cell Genomics
Zhongyi Wang, Senior Expert II Data Science, Novartis
Oct 714:35
Conference pass

Building an AI Agent on top of small language models to automate Molecular Dynamics simulations

Large Language Models
Guglielmo Iozzia, Director – Machine Learning/AI and Applied Mathematics, MSD
Oct 714:35
Conference pass

Workflow management

Digital Transformation
Oct 714:35
Conference pass

Bridging the gap; academic insights to regulatory approvals

Data Integration + FAIR
Elena Zhuravleva, Global Medical Science Leader, Oncology, Roche
Oct 714:35
Conference pass

Advancing OCT Analysis in nAMD and DR/DME Treatment

Analytics Platform
Christina Pamela Kreutzmann, Global AI Deployment Lead, Roche
Oct 714:35
Conference pass
Oct 714:35
Conference pass

Cross functional use of RWE

Real World Evidence
Diar Fattah, Global Director, Innovative Value Strategies And Evidence (Respiratory), AstraZeneca
Oct 714:55
Conference pass

Bring Data to Life, Generating Value from AI in Clinical Trials

AI in Clinical Trials
Tankred Ott, Senior Data Scientist, Novo Nordisk
Nanna Holmstrup, Program Director, Novo Nordisk
Oct 715:15
Conference pass

Revolutionising Drug Discovery: AI-Powered Identification of Therapeutic Targets

AI in Drug Development and Discovery
Lee Clewley, VP, AI & Informatics, e-therapeutics plc
Oct 715:15
Conference pass

AI for automatic Parkinson’s Disease Voice Assessment

Bioinformatics + In silico R&D
Parvaneh Janbakhshi, Data Scientist, Bayer
Oct 715:15
Conference pass

Decoding the regulatory genome through multi-omics integration to identify novel non-coding RNA targets

Single Cell Genomics
Oct 715:15
Conference pass

LLMs at Roche

Large Language Models
Bruno Gagliano, Expert Data Scientist, Roche
Oct 715:15
Conference pass

Reimagining Preclinical Systems: Leveraging GenAI and Knowledge Graph Techniques

Digital Transformation
Jobst Loeffler, Product Owner, Bayer
Oct 715:15
Conference pass

Empowering data science across functions with reusable modules

Analytics Platform
Philip Gebus, Principal AI Engineer, Bayer
Oct 715:15
Conference pass

An AI powered “neural system” that enriches operational decisions in Clinical Development

AI in Clinical Trials
Guillaume Carbonneau, Vice President, Operational Data Insights, Novo Nordisk
Abhishek Chatterjee, Head of Product Suite, Senior Director, Novo Nordisk
Nicklas Walldorf Gaardsted, Director, Head of Data & Modelling, Novo Nordisk
Oct 715:15
Conference pass

Simplify and accelerate access to RWD through AI

Real World Evidence
Leonardo D'Ambrosi, Principal Data Scientist, Bayer Pharma AG
Oct 715:15
Conference pass

Electron microscopy imaging and analysis for biotech and pharma R&D

Image Analysis
Andrzej Rzepiela, Lead Data Scientist, ETH
Oct 715:35
Conference pass

Broadening precision medicine through pharmacogenomics

Population Genomics
Oct 715:35
Conference pass

Unlocking the potential of hERVs as vaccine antigens

AI in Clinical Trials
Christian Garde, Director of Bioinformatics, Evaxion Biotech
Oct 715:55
Conference pass

Exploratory rare variant analysis in neurodegeneration using AI within UK Biobank and clinical trials

Population Genomics
Achim Kless, Senior Director Pain Genetics, Eli Lilly and Company
Oct 715:55
Conference pass

Implementing AI in Servier therapeutic projects

AI in Drug Development and Discovery
Francois-Xavier Blaudin de Thé, Therapeutic lead Data Digital and AI, SERVIER
Oct 715:55
Conference pass

Colorectal cancer liver metastasis subtypes and their trajectory

Bioinformatics + In silico R&D
Nerses Shahbazyan, Bioinformatics Scientist, Yerevan State Medical University
Oct 715:55
Conference pass

LLMs at the University of Zurich

Large Language Models
Ana Kotarcic, Researcher, NLP and Deep Learning, University of Zurich
Oct 715:55
Conference pass

How we apply behaviour science for transformation implication and cost efficiency

Digital Transformation
Oct 715:55
Conference pass

Data Integration + FAIR from a Roche perspective

Data Integration + FAIR
Roman Engel, Head Agile Document Flow - VPH, Roche
Oct 715:55
Conference pass

AI augmented analytics platforms in peptide optimisation

Analytics Platform
Andrea Possenti, Associate Principal Data Scientist, AstraZeneca
Oct 715:55
Conference pass

High uncertainty Decision making enabled by machine learning models

AI in Clinical Trials
Raul Mora, Senior Development Excellence Lead, Roche
Oct 715:55
Conference pass

simulations of the patient journey in CVD within the real world data sections.

Real World Evidence
Janne Martikainen, Professor (pharmacoeconomics), University of Eastern Finland
Oct 715:55
Conference pass

Revolutionizing Vascular Diagnostics: AI-Enhanced Flow Prediction from Static Medical Images

Image Analysis
Oct 716:05
Conference pass

Networking Break

Keynotes
Anna Abiola, Senior Producer, Terrapinn Holdings Ltd
Oct 716:45
Conference pass

Chair's remarks

AI in Drug Development and Discovery
Giovanni Rizzo, Partner Biotech Fund, Indaco Venture Partners
Oct 716:45
Conference pass

Chair's remarks

Large Language Models
Peter Vester, Lead Data Scientist, Novo Nordisk
Oct 716:45
Conference pass

Chair's remarks

Digital Transformation
Angelika Fuchs, Chapter Lead Data Products and Platforms, Roche
Oct 716:45
Conference pass

Chair's remarks

Data Integration + FAIR
Raed Haltam, Product Manager, Hofmann La Roche
Oct 716:45
Conference pass

Chair's remarks

Real World Evidence
Diar Fattah, Global Director, Innovative Value Strategies And Evidence (Respiratory), AstraZeneca
Oct 716:45
Conference pass

Chair's remarks

Image Analysis
Steffen Vogler, Senior Imaging Technology Scientist, Bayer
Oct 716:50
Conference pass

Developing Integrated Risk Scores for Cardiovascular Disease Prediction

Population Genomics
Panagiotis Deloukas, Director of William Harvey Institute,, Queen Mary University of London
Oct 716:50
Conference pass

Omics based off target prediction

Bioinformatics + In silico R&D
Beatriz Roson, Director, Bioinformatics, Astrazeneca
Oct 716:50
Conference pass

Real Value with GenAI in clinical Development

Large Language Models
Daryna Smyrnova, AI Lead for Clinical Development, UCB
Oct 716:50
Conference pass

Increasing engagement with digital health

Digital Transformation
Thomas Boillat, Senior Digital Health Product Lead, Roche
Oct 716:50
Conference pass

Insights in early stage developments

Data Integration + FAIR
Valentina Ranghetti, Customer Insights Lead, Roche
Oct 716:50
Conference pass

Servier’s Analytics Platform: Accelerating Science

Analytics Platform
Yannick Haudry, Lead Data Platform Product Manager, Servier
Oct 716:50
Conference pass

Next level knowledge management in clinical trials

AI in Clinical Trials
Nicola Goetz, Expert Clinical Data Engineer, Boehringer Ingelheim Pharma GmbH & Co KG
Oct 716:50
Conference pass

The World After the 23&Me Hangover: Four Pillars to Rebuild Precision Medicine From the Patient Up

Real World Evidence
Alessandro Riccombeni, CEO, Axia Medicine
Oct 716:50
Conference pass

Computation pathology in oncology drug development

Image Analysis
Christian Eisen, Director Translational Science, AstraZeneca
Oct 717:10
Conference pass

Innovative trial Design powered by Agentic AI & connected Insights

AI in Clinical Trials
Abhishek Chatterjee, Head of Product Suite, Senior Director, Novo Nordisk
Oct 717:30
Conference pass

Summary Panel Population Genomics

Population Genomics
Moderator: Jens Habermann, Director General, BBMRI-ERIC
Oct 717:30
Conference pass

The Road Map to Transitioning from Ad-hoc AI to Business Value Generating AI

AI in Drug Development and Discovery
Moderator: Carmen Miguel, Legal Director, Data Privacy, Alnylam
Jeff Milton, Chief Executive Officer, La Jolla Labs
Frederico Braga, Head of Digital and IT, Debiopharm
Raul Mora, Senior Development Excellence Lead, Roche
Oct 717:30
Conference pass
Oct 717:30
Conference pass

Challenges in validating the many in silico targets now being generated by AI

Single Cell Genomics
Moderator: Dan Crowley, Chief Executive Officer, RemedyBio
Jake Chen, Endowed Professor and Founding Director, SPARC, University of Alabama at Birmingham
Werngard Czechtizky, Executive Director Head of Medicinal Chemistry, AstraZeneca
Oct 717:30
Conference pass

AI Agents, the future of LLMs?

Large Language Models
Michael Schorpp, Head of Knowledge Management and AI, Boehringer Ingelheim International GmbH
Gregory Ryslik, CTO, Compass Pathways
Oct 717:30
Conference pass

The Impact of Digital Transformation on Product Delivery in Healthcare

Digital Transformation
Michele Siccardi, Executive Director, International Insights & Analytics (I&A), CSL Behring
Moderator: Anastassia Anastassopoulou, Advanced Analytics Strategy Director, Daiichii Sankyo Europe
Monika Trehan, M&A Lead Europe, Dr Reddys
Bárbara Fernandes de Souza, Digital Operations Specialist, CSL Behring
Oct 717:30
Conference pass

Master Data Management at AstraZeneca

Data Integration + FAIR
Habib Baghirov, Associate Director, AstraZeneca
Oct 717:30
Conference pass

Multi-modal AI in precision medicine education

Analytics Platform
Moderator: Neehar Kundurti, Faculty, tulane university school of medicine
Priyasma Bhoumik, Strategic Vendor Manager, PS AI Strategy Lead, Roche
Oct 717:30
Conference pass

The impact of AI on clinical trials within clinical development

AI in Clinical Trials
Moderator: Pascal Bouquet, Managing Partner, HealthTechPartners 42
Marion Legler, Head of Decision Science & AI, Bayer
Vincent Lepreux, Investment Director, Debiopharm Innovation Fund
Guillaume Carbonneau, Vice President, Operational Data Insights, Novo Nordisk
Oct 717:30
Conference pass

Adoption of Real-World Data and Real-World Evidence in regulatory decision-making

Real World Evidence
Moderator: Vassilis Bitsikas, Translational Data Science, Novartis
Crina Samarghitean, Medical Doctor, Tampere University
Oct 717:30
Conference pass

Unravelling the Impact of AI and Machine Learning in Image Analysis: Advancements, Challenges, and Future Directions in Pharma and Healthcare Industries

Image Analysis
Moderator: Andrzej Rzepiela, Lead Data Scientist, ETH
Oct 717:50
Conference pass

Ontologies in clinical trials using AI

Data Integration + FAIR
Raed Haltam, Product Manager, Hofmann La Roche
Oct 718:10
Conference pass

Networking Drinks Reception

Keynotes
Anna Abiola, Senior Producer, Terrapinn Holdings Ltd

Create your personal agenda –check the favourite icon

Oct 89:00
Conference pass

Chair's remarks

Keynotes
Joerg Degen, VP & Head of Computational Medicine, Roche
Oct 89:05
Conference pass

Personalised medicine through pharmacogenomics - making care safer, more effective and cost effective

Keynotes
Oct 89:25
Conference pass

Investor Panel: Backing the AI-Biology Frontier: Where Top Investors Are Placing Bets

Keynotes
Moderator: Rana Lonnen, General Partner, Science Capital Ventures
Lana Ghanem, Managing Director, Hikma Ventures/VP of Digital Health & Life Sciences Investements, Hikma Pharmaceuticals
Oct 811:05
Conference pass

Chair's remarks

AI in Drug Development and Discovery
Werngard Czechtizky, Executive Director Head of Medicinal Chemistry, AstraZeneca
Oct 811:05
Conference pass

Chair's remarks

Bioinformatics + In silico R&D
Oct 811:05
Conference pass

Chair's remarks

Large Language Models
Shawn Kyzer, Director, R&D IT - Data, Analytics & AI, Engineering, Astrazeneca
Oct 811:05
Conference pass

Chair's remarks

Digital Transformation
Syed Ali Shirazi, Head of Smart Factory, SANOFI
Oct 811:05
Conference pass

Chair's remarks

Data Integration + FAIR
Oct 811:05
Conference pass

Chair's remarks

Real World Evidence
Matthias Hartung, Data & AI Expert, Boehringer Ingelheim Pharma GmbH
Oct 811:05
Conference pass

Chair's remarks

Precision Medicine, Diagnostics and Therapies
Maria Guerrero, EMEA Product manager, Janssen
Oct 811:05
Conference pass

Chair's remarks

Lab Automation
Parag Dave, Head of Data, Digital, and Technology, Takeda
Oct 811:05
Conference pass

Chair's remarks

Quantum Pharma
John Wise, Consultant, Pistoia Alliance
Oct 811:05
Conference pass

Chair's remarks

Start up and innovation
Neehar Kundurti, Faculty, tulane university school of medicine
Oct 811:10
Conference pass

Harnessing AI for Smarter Drug Development

AI in Drug Development and Discovery
Joerg Degen, VP & Head of Computational Medicine, Roche
Oct 811:10
Conference pass

Approaches to precision therapeutics and clinical trial enhancements

Bioinformatics + In silico R&D
Mary Helen Black, SVP and Head of Genomics, Foresite Labs
Oct 811:10
Conference pass

LLMs inside company

Large Language Models
Robert Di Giovanni, Senior Global Patient Safety Lead, Novartis
Oct 811:10
Conference pass

Data strategy and Governance in R&D

Digital Transformation
Felipe Albrecht, Principal Scientist, pRED D&A Governance & Strategy, Roche
Oct 811:10
Conference pass

Shape a data-driven future: A Journey towards Data Integration, Data Management, and Organizational Success

Data Integration + FAIR
Oct 811:10
Conference pass

Transforming Analytics for Business Insights: From Standardization to Customization

Analytics Platform
Francesco Orsi, Data Science Manager, Roche
Oct 811:10
Conference pass

Stopping people from becoming patients - Harnessing the power of real-world data and omics to predict and pre-empt disease

Real World Evidence
Lykke Pedersen, Product Creator, Novo Nordisk
Oct 811:10
Conference pass

Unlocking the potential of cell-free RNA for liquid biopsy biomarker and diagnostics

Precision Medicine, Diagnostics and Therapies
Bogdan Mateescu, group leader, University of Zurich
Oct 811:10
Conference pass

End to end automation of laboratory workflows

Lab Automation
Felix Stemmer, Senior Scientist II, Novartis Pharma AG
Oct 811:10
Conference pass

Demonstration of quantum utility for pharma use case

Quantum Pharma
Clément Javerzac-Galy, Professor, group leader, FHNW
Oct 811:10
Conference pass

Mastering the Jungle of Real-World Data

Start up and innovation
Berber Snoeijer, CEO, ClinLine
Oct 811:20
Conference pass

Space Biotech – Harness the uniqueness of space to develop unearthly bioproducts!

Start up and innovation
Felix Steiner, Head of Business Development, Yuri
Oct 811:30
Conference pass

FAIRifying patient registries in hemoglobinopathy research

Bioinformatics + In silico R&D
Maria Xenophontos, Lab Scientific Officer - Bioinformatician, The Cyprus Institute of Neurology and Genetics
Oct 811:30
Conference pass

Streamling AI / LLM Verification Leveraging Centralized Solutions

Large Language Models
Mario Sanger, Senior AI / NLP engineer, AstraZeneca
Oct 811:30
Conference pass

Empowering AstraZeneca R&D with Self-service Data Products

Analytics Platform
Oct 811:30
Conference pass

From Prediction to Prevention: Intercepting Tumours Before They Begin

Start up and innovation
Austin Reed, CEO, InterceptX
Oct 811:40
Conference pass

Labgears – a knowledge hub for your team

Start up and innovation
Damian Graczyk, Software Development Manager, Adamed Pharma
Oct 811:50
Conference pass

AI in Drug Development at Sevier

AI in Drug Development and Discovery
Sofia Lotfi, Senior Data Scientist, Drug Discovery, Servier
Oct 811:50
Conference pass

Scaling the impact of In Silico R&D through user adoption and democratisation

Bioinformatics + In silico R&D
Oct 811:50
Conference pass

Information grounding of LLMs using knowledge graphs and documents

Large Language Models
Nikola Milosevic, Senior Computational Scientist, Bayer
Oct 811:50
Conference pass

Progressive policies on Data and AI to enable Digital Transformation

Digital Transformation
Oct 811:50
Conference pass

Development of a System for ADC Molecular Registration

Data Integration + FAIR
Phin Chooi, Senior Scientist, AstraZeneca
Oct 811:50
Conference pass

Patient journey modelling

Real World Evidence
Petra Nathan, Global Head of Implementation Science, Boehringer Ingelheim
Oct 811:50
Conference pass

Donor derived cell free DNA to personalise immunosuppression in transplantation

Precision Medicine, Diagnostics and Therapies
Oct 811:50
Conference pass

IT Landscape and Robotics in the lab

Lab Automation
Jiayi Tong, Data Engineer, Roche
Oct 811:50
Conference pass

Applications and comparisons of pharmaceutical quantum computing

Quantum Pharma
Johannes Galatsanos, Researcher at Center of Quantum Networks, Massachusetts Institute of Technology
Oct 811:50
Conference pass

Cracking the ‘code’ in Drug Discovery – InvirtuoLabs

Start up and innovation
Gianvito Grasso, Founder and CEO, InVirtuoLabs
Oct 812:10
Conference pass

Open source drug discovery

AI in Drug Development and Discovery
Jake Chen, Endowed Professor and Founding Director, SPARC, University of Alabama at Birmingham
Oct 812:10
Conference pass

Gen AI use cases in clinical quality

Large Language Models
Ioannis Spyroglou, Associate Director, Data Science, MSD
Oct 812:10
Conference pass

Multimodal Data Assets - Optimizing Drug Development with Actionable Data Insights

Data Integration + FAIR
Oct 812:10
Conference pass

Novel methylation enrichment technologies for liquid biopsies

Precision Medicine, Diagnostics and Therapies
Oct 812:10
Conference pass

Exploring the Quantum challenges and impact in pharma

Quantum Pharma
Benoit Lelong, Head of Group Data Platform, SERVIER
Oct 812:30
Conference pass

Leveraging AI to Accelerate Drug Development Pipelines

AI in Drug Development and Discovery
Prakash Rathi, Director, R&DIT, Data Analytics and AI, AstraZeneca
Oct 812:30
Conference pass

Machine learning prediction of picomolar affinity soluble T cell receptors

Bioinformatics + In silico R&D
Oct 812:30
Conference pass

Accelerating drug discovery with an AI KG-based Research Assistant chatbot

Large Language Models
Albert Maristany, Knowledge Graph Product Lead, Astrazeneca
Oct 812:30
Conference pass

Digital Transformation through AI and data analytics

Digital Transformation
Syed Ali Shirazi, Head of Smart Factory, SANOFI
Oct 812:30
Conference pass

The Power of an R&D Unified Data Catalog with Domain Models: Accelerating Insights and Enhancing Data Governance

Data Integration + FAIR
Friederike Stoll, Data Strategy & Governance, Bayer
Stefanie Holt-Noreiks, R&D Data Operations, Bayer AG
Oct 812:30
Conference pass

OCEAN: Roche’s “FAIR by Design” Analysis Platform Journey (SCE, CDR)

Analytics Platform
Ian Healy, Global Platforms Lead, Roche
Oct 812:30
Conference pass

Leveraging AI to transform social media content into real-world patient experience data

Real World Evidence
Matthias Hartung, Data & AI Expert, Boehringer Ingelheim Pharma GmbH
Oct 812:30
Conference pass

Precision anti-cancer agents, from checkpoint inhibitors to novel targeted therapies

Precision Medicine, Diagnostics and Therapies
Oct 812:30
Conference pass

Pitfalls on your way to successful lab automation and digitalisation

Lab Automation
Susanne Weissenborn, Team leader Enabling Technologies, Roche
Oct 812:30
Conference pass

Marama Labs - Breaking bottlenecks in chemical analysis of complex liquid

Start up and innovation
Brendan Darby, CEO, Marama Labs
Oct 813:20
Conference pass

Closing keynote panel: Future of AI & technologies in Neurological disorders

Keynotes
Amit Khanna, VP, Global Program HeadParkinson’s & Neuroscience Digital Programs, Novartis
Cristina Granziera, Professor, Neurology and Biomedical Engineering, University of Basel
Nikita Popov, Head AI Strategy Office, Novartis
last published: 08/Jul/25 15:55 GMT

Get involved at BioTechX

 

 

TO SPONSOR

Joshua Kennedy

joshua.kennedy@terrapinn.com

Jack Moseley

jack.moseley@terrapinn.com

 

 

TO SPEAK

Anna Abiola

anna.abiola@terrapinn.com

 

 

MARKETING OPPORTUNITIES

Karen Duncan
karen.duncan@terrapinn.com